<DOC>
	<DOC>NCT02068495</DOC>
	<brief_summary>This study will investigate the safety and efficacy of long-term use of candesartan cilexetil/amlodipine combination tablets (Unisia Combination Tablets) LD, HD in patients with hypertension in the normal clinical setting.</brief_summary>
	<brief_title>Candesartan Cilexetil/Amlodipine Combination Tablets LD, HD Special Drug Use Surveillance "Hypertension: Long-Term Use"</brief_title>
	<detailed_description>This special drug use surveillance was designed to investigate the safety and efficacy of long-term use of candesartan cilexetil/amlodipine combination tablets (Unisia Combination Tablets) in patients with hypertension in the routine clinical setting. The usual adult dosage is one tablet (8 mg/2.5 mg or 8 mg/5 mg as candesartan cilexetil/amlodipine) administered orally once daily.</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Patients with hypertension Patients in whom Unisia is contraindicated [Contraindications] 1. Patients with a history of hypersensitivity to the ingredients of Unisia or any other dihydropyridine formulations 2. Women who are pregnant or of childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Drug therapy</keyword>
</DOC>